Adverse Reactions to Biologics

Targeted Therapies in Dermatology, edited by L. Puig and W. Gulliver, with series editors P. Itin and G.B.E. Jemec, provides an in-depth exploration of the rapidly evolving field of immunologically targeted dermatologic treatments. The book addresses the challenges clinicians face in selecting therapies that maximize patient outcomes, particularly in chronic inflammatory and malignant skin conditions. By combining clinical expertise with cutting-edge research, it highlights both approved and off-label uses of biologics and other targeted therapies, emphasizing safety, efficacy, and practical management strategies for complex dermatologic patients.

Key Features

• Comprehensive coverage: Examines targeted therapies for chronic inflammatory skin disorders, autoimmune bullous diseases, and skin cancers.
• Safety and management focus: Discusses adverse reactions, infectious complications, paradoxical reactions, and perioperative considerations for biologic therapies.
• Evidence-based guidance: Provides insights into immunogenicity, efficacy, and risk mitigation strategies.
• Expert contributors: Written by leading clinicians and researchers with extensive practical experience.
• Clinical and translational relevance: Bridges the gap between immunopathogenesis understanding and real-world therapeutic application.
• Multidisciplinary appeal: Useful for dermatologists, oncologists, immunologists, and other healthcare professionals managing complex skin disorders.
• Practical insights: Offers strategies to optimize patient outcomes while navigating new and evolving therapeutic options. 

Product Details

• Series: Current Problems in Dermatology, Vol. 53 (Book 53)
  
• Publisher: S. Karger; 1 edition (November 30, 2017)
• Language: English
• ISBN-10: 331806100X
• ISBN-13: 978-3318061000